Every patient with cancer is looking for hope — especially hope for improved survival and cure. Cure of metastatic solid tumors has been an elusive goal. However, 10-year outcomes among patients with melanoma who were treated with nivolumab and ipilimumab, reported by Wolchok et al. in this issue of the…
The New England Journal of Medicine: Search Results in Hematology/Oncology
